Aug 25 (Reuters) - RaySearch Laboratories AB (publ)
RAYb.ST :
* INTERIM REPORT JANUARY 1 - JUNE 30, 2021
* Q2 ORDER INTAKE SEK 189.8 M (177.1)
* Q2 NET SALES SEK 154.6 M (163.8)
* Q2 OPERATING LOSS SEK -22.5 M (-10.9)
* COVID-19 PANDEMIC WITH TEMPORARY REPRIORITIZATIONS IN
HEALTHCARE
CONTINUED TO HAVE A NEGATIVE IMPACT ON SALES IN Q2
* RAYSEARCH EXPECTS THAT NEGATIVE EFFECTS OF COVID-19
PANDEMIC ON
COMPANY'S SALES AND EARNINGS WILL CONTINUE FOR SOME MONTHS TO
COME, MAINLY BECAUSE ORDERS MAY BE DELAYED.
* IN Q2 OF 2021, NET SALES DECLINED 6 PERCENT DUE TO LOWER
LICENSE
SALES
Source text for Eikon: ID:nWkr3szwjq
Further company coverage: RAYb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))